NGM Biopharmaceuticals (NGM) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $0.37 per share a year ago. These ...NGM gets a Bearish score from InvestorsObserver's Stock Sentiment Indicator. NGM Biopharmaceuticals Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on NGM!Trading Hours Summary: The Nordic Growth Market is open Monday through Friday from 9:00 am to 5:25 pm Central European Summer Time (GMT+02:00). The Nordic Growth Market does not close for lunch. The Nordic Growth Market is open for a total of 8 hours 25 minutes per day. The Nordic Growth Market does have extended hours trading.Aug 25, 2023 · The dividend schedule below includes dividend amounts, payment dates and ex-dividend dates for NGM Biopharmaceuticals. NGM Biopharmaceuticals issues dividends to shareholders from excess cash the ... Sep 1, 2023 · The stock of NGM Biopharmaceuticals Inc. (NGM) has gone down by -8.47% for the week, with a -11.68% drop in the past month and a -39.03% drop in the past quarter. The volatility ratio for the week is 7.50%, and the volatility levels for the past 30 days are 9.00% for NGM. Jun 30, 2023 · What's Happening With NGM Stock Today? NGM Biopharmaceuticals Inc (NGM) stock is trading at $2.62 as of 3:00 PM on Friday, Jun 30, an increase of $0.18, or 7.38% from the previous closing price of $2.44. The stock has traded between $2.44 and $2.66 so far today. Volume today is light. So far 238,866 shares have traded compared to average volume ... NGM Biopharmaceuticals: Q3 Earnings Snapshot. NGM : 3.80 (-3.31%) After Plunging 59.4% in 4 Weeks, Here's Why the Trend Might Reverse for NGM Biopharmaceuticals (NGM) Zacks - Thu Nov 3, 2022. The heavy selling pressure might have exhausted for NGM Biopharmaceuticals (NGM) as it is technically in oversold territory now. (See NGM stock analysis on TipRanks) ZipRecruiter . The next Raymond James pick we're looking at is ZipRecruiter, an online employment marketplace for both employers and job seekers. The company ...Sep 14, 2023 · NAAS) stock’s latest price update. NaaS Technology Inc. (NASDAQ: NAAS)’s stock price has gone rise by 1.03 in comparison to its previous close of 5.85, however, the company has experienced a -3.43% decrease in its stock price over the last five trading days. NGM Biopharmaceuticals Inc stock is lower by -91.25% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NGM stock a score of 35 out of a possible 100.Sep 1, 2023 · The stock of NGM Biopharmaceuticals Inc. (NGM) has gone down by -8.47% for the week, with a -11.68% drop in the past month and a -39.03% drop in the past quarter. The volatility ratio for the week is 7.50%, and the volatility levels for the past 30 days are 9.00% for NGM. The Exchange. Nordic Growth Market NGM AB, which is owned by Börse Stuttgart, is a Swedish stock exchange with authorization from the Swedish Financial Supervisory Authority to operate a regulated market, Main Regulated, a multilateral trading platform, Nordic MTF, and an SME Growth Market, Nordic SME. On the regulated market Main Regulated ... According to the issued ratings of 3 analysts in the last year, the consensus rating for Origin Materials stock is Hold based on the current 2 hold ratings and 1 buy rating for ORGN. The average twelve-month price prediction for Origin Materials is $6.00 with a high price target of $6.00 and a low price target of $6.00.Shares of NGM Biopharmaceuticals ( NASDAQ:NGM) are tanking today after the topline results from its Phase 2 study of NGM621 for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) showed that the drug failed to meet the primary endpoints. Further details and findings from this study are anticipated in ...Get the latest NGM Biopharmaceuticals Inc (NGM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Aug 19, 2023 · During the last session, NGM Biopharmaceuticals Inc. (NASDAQ:NGM)’s traded shares were 0.32 million, with the beta value of the company hitting 1.13. The 52-week high for the NGM share is $16.91, that puts it down -672.15 from that peak though still a striking 11.87% gain since the share price See the latest NGM Biopharmaceuticals Inc stock price (XFRA:0IK), related news, valuation, dividends and more to help you make your investing decisions.Aug 25, 2023 · NGM support price is $1.94 and resistance is $2.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NGM stock will trade within this expected range on the day. National Geographic is the source for pictures, photo tips, free desktop wallpapers of places, animals, nature, underwater, travel, and more, as well as photographer bios.US62921N1054. NGM Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for cardio-metabolic, liver, oncologic, and ophthalmic diseases. Its lead product candidate, aldafermin, is designed for the treatment of patients with non-alcoholic steatohepatitis, with liver ...The NGM Biopharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.NGM Biopharmaceuticals Inc’s trailing 12-month revenue is $29.8 million with a -569.9% profit margin. Year-over-year quarterly sales growth most recently was -83.1%. Analysts expect adjusted earnings to reach $-1.920 per share for the current fiscal year. NGM Biopharmaceuticals Inc does not currently pay a dividend.Stock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for NGM stock stock is $6.40, which predicts an increase of 220.00%. The lowest target is $4.00 and the highest is $9.00. On average, analysts rate NGM stock stock as a buy.NGM Bio’s product candidates in a timely manner, or at all; seeking and maintaining protection of intellectual property; NGM Bio’s reliance on third party manufacturers and delays or problems in the manufacture or testing of product candidates; NGM Bio’s dependence on its amended collaboration with Merck for the development and potential ... Sep 8, 2023 · According to the issued ratings of 3 analysts in the last year, the consensus rating for Origin Materials stock is Hold based on the current 2 hold ratings and 1 buy rating for ORGN. The average twelve-month price prediction for Origin Materials is $6.00 with a high price target of $6.00 and a low price target of $6.00. NGM Bio’s webpage declares "We're Hiring!" but a peek at the investor relations section of the biotech’s website tells a different—and sobering—story. In fact, the developer of four solid ...Find the latest NeoGames S.A. (NGMS) stock quote, history, news and other vital information to help you with your stock trading and investing. Aug 2, 2023 · Forecst.com predicts future values using technical analysis of a large number of analytical parameters. NGM stock returns are also predicted based on historical data. According to our research, NGM stock is a bad long-term investment. NGM share price has been in a bear cycle for the past year. NGM Biopharmaceuticals, Inc. stock trend is negative . NGM Biopharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on discovering and developing novel, potentially life-changing medicines based on scientific understanding of key biological pathways underlying grievous diseases with critical unmet or underserved patient need.NGM Biopharmaceuticals (NGM) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $0.37 per share a year ago. These ...See the latest NGM Biopharmaceuticals Inc stock price (XFRA:0IK), related news, valuation, dividends and more to help you make your investing decisions.pakistan international airlines
NGM’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are ...Current Stock Price for NGM Biopharmaceuticals (NGM)? A. The stock price for NGM Biopharmaceuticals ( NASDAQ: NGM) is $ 3.25 last updated June 2, 2023 at 8:00 PM UTC. Q.NGM Bio’s webpage declares "We're Hiring!" but a peek at the investor relations section of the biotech’s website tells a different—and sobering—story. In fact, the developer of four solid ... NGM Biopharmaceuticals Insider Trading Activity 2023 (NASDAQ:NGM) S&P 500. QQQ. Nokia renews patent license agreement with Apple, covering 5G and other technologies. Children face solitary confinement in cells at Illinois juvenile detention facility, ACLU says.NGM gets a Bearish score from InvestorsObserver's Stock Sentiment Indicator. NGM Biopharmaceuticals Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on NGM!Sep 14, 2023 · NAAS) stock’s latest price update. NaaS Technology Inc. (NASDAQ: NAAS)’s stock price has gone rise by 1.03 in comparison to its previous close of 5.85, however, the company has experienced a -3.43% decrease in its stock price over the last five trading days. Get the latest NGM Biopharmaceuticals Inc (NGM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.NGM Biopharmaceuticals (NGM) shares plunged 72% on Monday, from $11.53 to $3.41, after the company acknowledged that its eye disorder candidate NGM621 failed the Phase II CATALINA trial ...NGM Biopharmaceuticals Inc stock is lower by -91.25% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NGM stock a score of 35 out of a possible 100.mercury oculus
Nordic Growth Market (NGM Exchange) is a regulated exchange that delivers trading, exchange technology and public company services. The exchange operates in Sweden, Finland, Denmark, and Norway and was established in 1984. Since 2008, Nordic Growth Market is a fully owned subsidiary of Börse Stuttgart, one of the leading exchanges in Europe.Aug 2, 2023 · Forecst.com predicts future values using technical analysis of a large number of analytical parameters. NGM stock returns are also predicted based on historical data. According to our research, NGM stock is a bad long-term investment. NGM share price has been in a bear cycle for the past year. NGM Biopharmaceuticals, Inc. stock trend is negative . NGM Bio is focused on discovering and developing novel, life-changing medicines for people whose health and lives have been disrupted by disease. The company’s biology-centric drug discovery approach aims to seamlessly integrate interrogation of complex disease-associated biology and protein engineering expertise to unlock proprietary ...Sep 14, 2023 · NAAS) stock’s latest price update. NaaS Technology Inc. (NASDAQ: NAAS)’s stock price has gone rise by 1.03 in comparison to its previous close of 5.85, however, the company has experienced a -3.43% decrease in its stock price over the last five trading days. National Geographic is the source for pictures, photo tips, free desktop wallpapers of places, animals, nature, underwater, travel, and more, as well as photographer bios. NGM Biopharmaceuticals (NGM) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $0.37 per share a year ago. These ...Jul 26, 2023 · NGM’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are ... Company Summary. NGM Biopharmaceuticals Inc. is focused on developing novel therapeutics for underlying cardio-metabolic, liver, oncologic and ophthalmic diseases. The company's product pipeline ...Find the latest NeoGames S.A. (NGMS) stock quote, history, news and other vital information to help you with your stock trading and investing.Sep 14, 2023 · NAAS) stock’s latest price update. NaaS Technology Inc. (NASDAQ: NAAS)’s stock price has gone rise by 1.03 in comparison to its previous close of 5.85, however, the company has experienced a -3.43% decrease in its stock price over the last five trading days. watch the last naruto movie
National Geographic Stock. A man opens a set of sliding doors on the island of Okinawa. Covering only 454 square miles (1,176 square kilometers), Okinawa is noted for its fine beaches and for the long life expectancy of native islanders, who maintain ancient values and a vibrant culture distinct from that of mainland Japan. Two Japanese ...Nordic Growth Market (NGM Exchange) is a regulated exchange that delivers trading, exchange technology and public company services. The exchange operates in Sweden, Finland, Denmark, and Norway and was established in 1984. Since 2008, Nordic Growth Market is a fully owned subsidiary of Börse Stuttgart, one of the leading exchanges in Europe. NGM Biopharmaceuticals, Inc. Common Stock (NGM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Why has NGM's stock price moved recently? (Hint: Our stock research tools can help you evaluate if NGM is a good stock to buy). Execute your NGM trade: Decide if you will purchase ; NGM shares at the current market price or use a limit order to buy NGM stock at a specific price.Track your investment in NGM: Create a watchlist to ; important ...Upon receipt of a strain request, the CGC will send a response confirming that the order has been received. The requested strains are either thawed from a freezer vial or recovered from a starved plate kept in an incubator at 11 ° C. Animals of each strain are placed on freshly prepared Nematode Growth Medium (NGM) petri plates that have been spread with E. coli as a source of food and ...NGM Biopharmaceuticals Inc stock has fallen -76.46% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NGM stock a score of 33 out of a possible 100.(See NGM stock analysis on TipRanks) ZipRecruiter . The next Raymond James pick we're looking at is ZipRecruiter, an online employment marketplace for both employers and job seekers. The company ...For Wire Transfers of Stock Stock transfers are processed through Merrill Lynch of Bank of America . Merrill Lynch – DTC # 8862 National Geographic Society Account: 7WD-03781 *Please indicate that it is a gift. Contact Information Primary Contact: Gigi Peterson (202) 659-6122 [email protected] . or James King (202) 659-6055 [email protected] Forecst.com predicts future values using technical analysis of a large number of analytical parameters. NGM stock returns are also predicted based on historical data. According to our research, NGM stock is a bad long-term investment. NGM share price has been in a bear cycle for the past year. NGM Biopharmaceuticals, Inc. stock trend is negative .View the latest NGM Biopharmaceuticals Inc. (NGM) stock price, news, historical charts, analyst ratings and financial information from WSJ. Aug 23, 2023 · The NGM Biopharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention. NGM Biopharmaceuticals Inc (NGM) Stock Price & News - Google Finance Markets US Europe Asia Dow Jones 13,631.05 1,895.75 Home NGM • NASDAQ NGM Biopharmaceuticals Inc Follow Share $2.05 After...Trading Hours Summary: The Nordic Growth Market is open Monday through Friday from 9:00 am to 5:25 pm Central European Summer Time (GMT+02:00). The Nordic Growth Market does not close for lunch. The Nordic Growth Market is open for a total of 8 hours 25 minutes per day. The Nordic Growth Market does have extended hours trading.General stock maintenance tips. C. elegans stocks can best be maintained between 16 ° C and 25 ° C, most typically at 20 ° C. C. elegans grows 2.1 times faster at 25 ° C than at 16 ° C, and 1.3 times faster at 20 ° C than at 16 ° C ( Maniatis et al., 1982 ). Complete NGM Biopharmaceuticals Inc. stock information by Barron's. View real-time NGM stock price and news, along with industry-best analysis.the rookie feds episodes
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that updated preliminary findings from its open-label Phase 1a dose escalation study of NGM120, a novel ... NGM Biopharmaceuticals Inc stock is lower by -91.25% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NGM stock a score of 35 out of a possible 100.What's Happening With NGM Stock Today? More About NGM Biopharmaceuticals Inc NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases.Sep 11, 2023 · NGM Biopharmaceuticals Inc’s trailing 12-month revenue is $29.8 million with a -569.9% profit margin. Year-over-year quarterly sales growth most recently was -83.1%. Analysts expect adjusted earnings to reach $-1.920 per share for the current fiscal year. NGM Biopharmaceuticals Inc does not currently pay a dividend. Shares of NGM Biopharmaceuticals ( NASDAQ:NGM) are tanking today after the topline results from its Phase 2 study of NGM621 for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) showed that the drug failed to meet the primary endpoints. Further details and findings from this study are anticipated in ...NGM Bio’s webpage declares "We're Hiring!" but a peek at the investor relations section of the biotech’s website tells a different—and sobering—story. In fact, the developer of four solid ...Sep 15, 2023 · NGM Biopharmaceuticals Inc stock is lower by -91.25% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NGM stock a score of 35 out of a possible 100. The average price recommended by analysts for NGM Biopharmaceuticals Inc. (NGM) is $5.40, which is $3.6 above the current market price. The public float for NGM is 64.85M and currently, short sellers hold a 5.04% of that float. On August 25, 2023, NGM’s average trading volume was 321.70K shares. The artificial intelligence (AI) revolution is ...Jun 1, 2021 · NGM : NGM Biopharmaceuticals stock forecast by Wall Street Analysts. The average NGM Biopharmaceuticals stock forecast from last 6 month is $6.5, and this show a -12.5% decrease in average from the prior price target of the each prediction. The mean of analysts' price targets for NGM Biopharmaceuticals (NGM) points to a 461.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...Google Finance provides real-time market quotes, international exchanges, up-to-date financial news, and analytics to help you make more informed trading and investment decisions. Stock Price Forecast The 4 analysts offering 12-month price forecasts for NGM Biopharmaceuticals Inc have a median target of 5.00, with a high estimate of 9.00 and a low estimate of 2.00. NGM Biopharmaceuticals, Inc. Common Stock (NGM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.knixs comAt NGM, we are charting new paths and pushing beyond boundaries to discover and deliver medicines for people whose health and lives have been disrupted by disease. NGM Bio Presents Preliminary Data from Phase 1 Monotherapy Dose Escalation Trial of NGM707 in Patients with Advanced or Metastatic Solid Tumors at 2022 ESMO-IO Annual MeetingSee the latest NGM Biopharmaceuticals Inc stock price (XFRA:0IK), related news, valuation, dividends and more to help you make your investing decisions.National Geographic Stock. A man opens a set of sliding doors on the island of Okinawa. Covering only 454 square miles (1,176 square kilometers), Okinawa is noted for its fine beaches and for the long life expectancy of native islanders, who maintain ancient values and a vibrant culture distinct from that of mainland Japan. Two Japanese ... Nevada Gold Mines is a joint venture between Barrick (61.5%) and Newmont (38.5%) that combined our significant assets across Nevada in 2019 to create the single largest gold-producing complex in the world.Dec 7, 2022 · At NGM, we are charting new paths and pushing beyond boundaries to discover and deliver medicines for people whose health and lives have been disrupted by disease. NGM Bio Presents Preliminary Data from Phase 1 Monotherapy Dose Escalation Trial of NGM707 in Patients with Advanced or Metastatic Solid Tumors at 2022 ESMO-IO Annual Meeting National Geographic is the source for pictures, photo tips, free desktop wallpapers of places, animals, nature, underwater, travel, and more, as well as photographer bios.Ngm Biopharmaceuticals, Inc. (Ngm Bio) Announces Topline Efficacy and Safety Results from Its Randomized, Double-Masked, Sham-Controlled Catalina Phase 2 Trial of Ngm621 in Patients with Geographic Atrophy (Ga) Secondary to Age-Related Macular Degeneration1,855.76 -18.52(-0.99%) Crude Oil 86.77 -0.77(-0.88%) Gold 1,944.00 -0.20(-0.01%) PROGRAMMING ALERT: NEXT, a new series by Yahoo Finance, debuts Friday, September 8, at 10 a.m. ET NGM...Ngm Biopharmaceuticals, Inc. (Ngm Bio) Announces Topline Efficacy and Safety Results from Its Randomized, Double-Masked, Sham-Controlled Catalina Phase 2 Trial of Ngm621 in Patients with Geographic Atrophy (Ga) Secondary to Age-Related Macular DegenerationNGM Biopharmaceuticals Inc stock has fallen -76.46% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NGM stock a score of 33 out of a possible 100.Get the latest NGM Biopharmaceuticals Inc (NGM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Trading Hours Summary: The Nordic Growth Market is open Monday through Friday from 9:00 am to 5:25 pm Central European Summer Time (GMT+02:00). The Nordic Growth Market does not close for lunch. The Nordic Growth Market is open for a total of 8 hours 25 minutes per day. The Nordic Growth Market does have extended hours trading.Aug 25, 2023 · The average price recommended by analysts for NGM Biopharmaceuticals Inc. (NGM) is $5.40, which is $3.6 above the current market price. The public float for NGM is 64.85M and currently, short sellers hold a 5.04% of that float. On August 25, 2023, NGM’s average trading volume was 321.70K shares. The artificial intelligence (AI) revolution is ... watch you're next
Jun 30, 2023 · What's Happening With NGM Stock Today? NGM Biopharmaceuticals Inc (NGM) stock is trading at $2.62 as of 3:00 PM on Friday, Jun 30, an increase of $0.18, or 7.38% from the previous closing price of $2.44. The stock has traded between $2.44 and $2.66 so far today. Volume today is light. So far 238,866 shares have traded compared to average volume ... NGM Bio’s product candidates in a timely manner, or at all; seeking and maintaining protection of intellectual property; NGM Bio’s reliance on third party manufacturers and delays or problems in the manufacture or testing of product candidates; NGM Bio’s dependence on its amended collaboration with Merck for the development and potential ... Analyst Forecast. According to 7 analysts, the average rating for NGM stock is "Buy." The 12-month stock price forecast is $6.4, which is an increase of 312.90% from the latest price.Jun 30, 2023 · NGM Biopharmaceuticals Insider Trading Activity 2023 (NASDAQ:NGM) S&P 500. QQQ. Nokia renews patent license agreement with Apple, covering 5G and other technologies. Children face solitary confinement in cells at Illinois juvenile detention facility, ACLU says. Google Finance provides real-time market quotes, international exchanges, up-to-date financial news, and analytics to help you make more informed trading and investment decisions.National Geographic is the source for pictures, photo tips, free desktop wallpapers of places, animals, nature, underwater, travel, and more, as well as photographer bios.Complete NGM Biopharmaceuticals Inc. stock information by Barron's. View real-time NGM stock price and news, along with industry-best analysis.52 Week High Date 08/11/22. 52 Week Low 2.92. 52 Week Low Date 10/17/22. Market Cap 370.075M. Shares Out 82.06M. 10 Day Average Volume 0.29M. Dividend -. Dividend Yield -. Beta 1.19.The NGM Biopharmaceuticals Inc. stock price fell by -4.32% on the last day (Friday, 8th Sep 2023) from $1.62 to $1.55. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 7.24% from a day low at $1.52 to a day high of $1.63. The price has fallen in 7 of the last 10 days and is down by -24.94% for this period.xdeu no poste
Discover historical prices for NGM stock on Yahoo Finance. View daily, weekly or monthly format back to when NGM Biopharmaceuticals, Inc. stock was issued.Complete NGM Biopharmaceuticals Inc. stock information by Barron's. View real-time NGM stock price and news, along with industry-best analysis. NGM Biopharmaceuticals: Q3 Earnings Snapshot. NGM : 3.80 (-3.31%) After Plunging 59.4% in 4 Weeks, Here's Why the Trend Might Reverse for NGM Biopharmaceuticals (NGM) Zacks - Thu Nov 3, 2022. The heavy selling pressure might have exhausted for NGM Biopharmaceuticals (NGM) as it is technically in oversold territory now. Stock Price Forecast The 4 analysts offering 12-month price forecasts for NGM Biopharmaceuticals Inc have a median target of 5.00, with a high estimate of 9.00 and a low estimate of 2.00. What's Happening With NGM Stock Today? More About NGM Biopharmaceuticals Inc NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases.